Health news
U.S. Open and Olympic Champion Will Lead Integration of AI-Powered Coaching Platform Into Golf — App Beta to Open April 23
Mustard Logo
…
The post Justin Rose Joins Mustard Golf as Brand Ambassador first appeared on RSVTV news.
The post Justin Rose Joins Mustard Golf as Brand Ambassador appeared first on IGP Beauty.
The innovative new feature within the Parky app for Apple Watch is available by prescription for people with Parkinson’s disease.
ANKARA, Turkey, April 11, 2024 (Newswire.com)
–
h2o therapeutics today announced that Foggy, the company’s haptic cueing feature, is now available by prescription. The feature is classified as a Class II Medical Device by the U.S. Food and Drug Administration (FDA).
Parkinson’s disease affects millions worldwide, presenting unique challenges to both patients and caregivers. Freezing of gait is when someone may have temporary episodes of an inability to step forward. This abnormal gait pattern, in particular, significantly impacts mobility and independence, often leading to falls and decreased quality of life.
Foggy uses the Taptic Engine in Apple Watch to provide vibrotactile stimulation for individuals experiencing freezing of gait, a debilitating symptom of Parkinson’s disease. Users can simply tap a complication on their Apple Watch to initiate haptic feedback that helps with the condition.
“Cueing strategies hold immense promise in aiding individuals with freezing of gait,” says Yagmur Selin Gulmus, founder of h2o therapeutics. “However, the key to their effectiveness lies in accessibility, individualization, and ease of use. Our introduction of Foggy marks a significant advancement in the field, offering patients a non-invasive solution by simply wearing their Apple Watch, designed to assist without adding cognitive load.”
h2o conducted two clinical studies to explore different cueing methods, including audio and visual cues using augmented reality. By collaborating closely with the Parkinson’s community, the company gained valuable insights into patients’ specific needs and preferences. In response, h2o developed Foggy, a user-friendly app tailored to the unique requirements of people living with Parkinson’s disease.
“We’re excited to launch Foggy on World Parkinson’s Day, highlighting a major step in our fight against the tricky problem of freezing of gait, a condition full of unknowns,” explains Gulmus. “Foggy is a starting point towards tackling this issue that only a wealth of real-world data can clarify. Besides haptic cue generation, Foggy also acts as a data platform. This allows us to better understand freezing of gait and individualize our technology to meet the specific needs of those experiencing it.”
In 2022, h2o therapeutics obtained 510(k) marketing clearance from the U.S. Food and Drug Administration for its prescription mobile app, Parky, designed for monitoring Parkinson’s Disease. Integrated into Parky is the new Class II feature, Foggy, enhancing the app’s capabilities with a holistic approach to manage Parkinson’s symptoms. Parky app enables real-time monitoring of symptoms like tremors and dyskinesia through integration with Apple Watch using the Movement Disorder API; with the addition of Foggy, it now offers even more comprehensive support for patients. This innovation is a valuable tool for facilitating the exchange of meaningful and reliable data between patients and medical professionals, aiding in a better understanding and management of the disease.
Contact Information:
Bulutay Gunes
Brand Manager
Gokce Temizas
Commercial Officer
Original Source:
h2o Announces FDA Listing of Apple Watch-Based Cueing Feature ‘Foggy’ for Freezing of Gait in Parkinson’s Disease
HealthVerity to enhance its Media Measurement and Audience Manager solutions using Throtle’s data pixel technology for precise campaign targeting and attribution.
RED BANK, N.J., April 11, 2024 (Newswire.com)
–
Throtle, healthcare’s only dedicated identity company, announced today its data pixel technology will be used by HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science. Throtle’s pixel technology will enhance HealthVerity Media Measurement, a campaign attribution solution, as well as Audience Manager for precision targeting. The collaboration promises to provide unparalleled data insights for improved campaign efficacy.
Throtle’s powerful pixel technology enables the capture of valuable traffic data, which is then matched against their proprietary healthcare identity graph. The integration of these datasets allows for Throtle ID (TID) generation, a unique identifier that provides deep insights into customer behavior and campaign performance.
In turn, HealthVerity has established the nation’s largest privacy-protected healthcare data ecosystem by assigning patients a unique but persistent identifier, known as a HealthVerity ID (HVID), that allows patient identities to be accurately resolved over time and across data sources in a HIPAA-compliant manner. Media Measurement synchronizes the TID and HVID to provide the most comprehensive view of the patient journey that includes ad impressions and actual patient behavior, allowing for real-time campaign attribution and optimization. Using Audience Manager, self-directed analytics can be performed, while remaining HIPAA compliant, to gain a deeper understanding of patient behavior and more precisely target optimal audience segments.
The Throtle and HealthVerity collaboration unlocks a myriad of measurement use cases, enabling an unprecedented level of analysis and optimization for healthcare marketing efforts. This collaboration not only enhances the accuracy of campaign measurement, but also empowers marketers to make data-driven decisions, ensuring their messages reach the right audience at the right time with the right impact.
“Throtle is thrilled to collaborate with HealthVerity to bring our advanced identity resolution capabilities to the forefront of healthcare marketing,” said Chris Neuner, President of Throtle. “By leveraging our data pixel technology, HealthVerity can offer their clients a deeper understanding of their campaign performance and audience engagement, setting a new standard for precision in healthcare marketing analytics.”
Andrew Kress, CEO of HealthVerity, also expressed enthusiasm about the relationship, stating, “By synchronizing Throtle’s leading consumer identity resolution with our best-in-class patient identity resolution, our Media Measurement and Audience Manager solutions can provide pharmaceutical companies with previously unattainable insights. Working with Throtle is a testament to our commitment to innovation and our continuous effort to provide the life sciences industry with cutting-edge solutions that drive better outcomes for everyone involved.”
This collaboration brings together the strengths of identity resolution and data synchronization to deliver superior insights on the patient journey. As both companies continue to push the boundaries of what is possible in healthcare data analytics, the industry can look forward to more personalized, efficient, and effective marketing strategies that benefit healthcare providers and patients alike.
Contact Information:
Maggie Jordan
CSO
Original Source:
Throtle’s Data Pixel Technology to Enhance HealthVerity Media Measurement and Audience Manager Solutions
Great Plains Tribal Leaders Health Board and Federal Agencies to Join Effort
GPTLHB Great Plains Tribal Leaders Health Board
…
Developer of the sam wearable ultrasound technology launches a unique opportunity for students and healthcare professionals to support costs of education or research.
…
Ponte Vedra Plastic Surgery 2024 Logo
PONTE VEDRA BEACH, Fla., April 9, 2024 (Newswire.com)
–
Ascend Plastic Surgery Partners is pleased to announce i…
TAG, Inc. is driving innovation and excellence in healthcare procure-to-pay solutions with significant growth initiatives and expanded team expertise.
…
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets
…
Phase 1a study of first hormone-free male pill completes enrollment
MCI Logo
DURHAM, N.C., March 27, 2024 (Newswir…
Facilitating seamless doctor-patient communication and alleviating burnout for healthcare professionals
HIPAA Compliant SmartChat Assistant
…
